Aurobindo Pharma – APL Health Care Limited (Unit 1) Telangana Walk-In Interview on 14th February 2026 check here

Aurobindo Pharma (APL Health Care Limited) Walk-In Interview 2026 | Production, Engineering & QA | Telangana

Organization Name: Aurobindo Pharma – APL Health Care Limited (Unit 1) Telangana Walk-In Interview on 14th February 2026 check here

Walk-In Interview: 14th February 2026 | 09:00 AM – 01:00 PM

Location: TSIC SEZ, Polepally, Jadcherla, Mahabubnagar District, Telangana – 509301

Department: Production, Engineering, QA

Email ID: sankararoo.chitikela@aurobindo.com

Registration Link (QR): Scan QR Code for Registration

[ads id="ads1"]

Walk-In Interview Details

Company: APL Health Care Limited – Unit 1 (Aurobindo Pharma Group)

Date: Saturday, 14th February 2026

Timings: 09:00 AM to 01:00 PM

Interview & Work Location: APL Health Care Limited Unit 1, TSIC SEZ, Polepally, Jadcherla, Mahabubnagar District, Telangana – 509301

[ads id="ads1"]

Department Wise Vacancy Details

1. Production Department

Work Area: Granulation, Compression, Coating, Capsule Filling
Positions: TA / Sr. TA / Executive
Qualification: ITI / Diploma / Degree / B.Pharmacy
Experience: 3 – 8 Years

2. Engineering Department

Work Area: Process, Packing, HVAC
Positions: TA / Sr. TA / Executive
Qualification: ITI / Diploma / B.Tech
Experience: 3 – 8 Years

3. QA Department

Work Area: QMS, RA Validations
Position: Executive
Qualification: B.Pharmacy
Experience: 3 – 8 Years

[ads id="ads1"]

Documents Required

Updated Resume
Educational Documents
PAN Card
Aadhar Card
Recent Increment Letter with CTC
Last 3 Months Payslips
Bank Statement

Contact Details

Email: sankararoo.chitikela@aurobindo.com

Disclaimer

Aurobindo and its group companies follow a strict merit-based recruitment process. The company does not charge fee or accept any form of payment or security deposit from job seekers during any stage of recruitment process. Any communication claiming Aurobindo Pharma offering employment in exchange for money is fraudulent. The company shall not be held liable for any loss or damage resulting from such fraudulent communications or actions.